The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.19793
Abstract: Glioma is regarded as the most prevalent malignant carcinoma of the central nervous system, and lack of effective treatment. Thus, the development of new therapeutic strategies targeting glioma is of significant clinical importance. In the… read more here.
Keywords: jmjd3; inhibitor gsk; glioma; treatment ... See more keywords